Columbia Technology Ventures

Vps26a heterozygous mice for studying the retromer core in Alzheimer's disease

This technology is a transgenic mouse line with Vps26a heterozygous knockout that can be used to study the role of the retromer core in Alzheimer’s disease.

Unmet Need: Mouse model for studying retromer dedicated to endosomal recycling

Pathogenic disruptions in retromer-mediated endosomal trafficking are observed in Alzheimer’s disease (AD). Disruption in the retromer pathway impacts different brain regions with various severity, and the underlying mechanisms of the disease remain unknown. Although a target for studying AD pathology, there are currently no dedicated mouse models to selectively disrupt this pathway.

The Technology: Vps26a transgenic mice for studying retromer complex in neurological disorders

This technology describes a transgenic mouse line with heterozygous knockout of Vps26a. Western blot analysis confirmed a reduction in Vps26 protein level, but the mice survive into adulthood with no developmental abnormalities. Hippocampal-dependent memory function deficits have been observed in this mouse line with memory-related behavior tasks. This mouse line can also be used to compare with the knockout of other retromer-related genes.

Applications:

  • Mouse model for studying neurodegenerative diseases
  • Mouse model for studying prenatal and developmental disorders
  • Research tool for analysis of retromer function in different brain regions
  • Selection of therapeutic drugs targeting retromer complex

Advantages:

  • Specific targeting of Vps26a
  • Heterozygous line for partial loss-of-function
  • Comparable to other transgenic mouse lines

Lead Inventor:

Scott A. Small, M.D.

Related Publications:

Tech Ventures Reference: